Immunohistochemistry Market - Global Industry Analysis And Forecast To 2027
Published On : December 2018 Pages : 130 Category: Biotechnology Report Code : HC122160
Immunohistochemistry Market By Product (Reagents, Kits, Antibodies and Equipment); Application (Drug Testing and Diagnostics); and End-Use (Research Institutes, Hospitals and Diagnostic Laboratories and Others); - Global Industry Analysis And Forecast To 2027
Industry Outlook
Immunohistochemistry is a method of detecting antigens in a part of cells of tissue by utilizing the antibodies binding to the antigens in biological tissues. Immunohistochemistry is derived from base words “immuno” for the antibodies involved and “histo” means tissue. Use of Immunohistochemistry is growing due to factors like; application in diagnosis of abnormal cells like the once in cancer, understanding the distribution and localization of biomarkers, increasing number of cancer cases which demands for perfect diagnosis, more useful than the traditional enzyme staining technique as it deals with specific antigen- antibody reaction, rising expenditure on healthcare sector which involve good medical practices & care facilities, increase in the aged population, etc. Therefore, the Immunohistochemistry Market is anticipated to expand and has tremendous scope during the forecast period. The global Immunohistochemistry Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global Immunohistochemistry Market is based on segment, by Product the market is segmented into Reagents, Kits, Antibodies and Equipment; by Application the market is segmented into Drug Testing and Diagnostics; and by End-Use the market is segmented into Research Institutes, Hospitals and Diagnostic Laboratories and Others.
- Immunohistochemistry Market, By Product
- Reagents
- Kits
- Antibodies
- Equipment
- Immunohistochemistry Market, By Application
- Drug Testing
- Diagnostics
- Immunohistochemistry Market, By End-Use
- Research Institutes
- Hospitals and Diagnostic Laboratories
- Others
Regional Insights
On a global front, the Immunohistochemistry Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Immunohistochemistry Market, due to development of biotechnology market and introduction of new products.
Immunohistochemistry Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are Thermo Fisher Scientific Inc., Danaher Corporation, Abcam plc, Merck KGaA , Bio-Rad Laboratories Inc., PerkinElmer Inc., F. Hoffmann-La Roche AG, Agilent Technologies, Bio SB and Cell Signaling Technology Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abcam plc.
- Merck KGaA
- Bio-Rad Laboratories Inc.
- PerkinElmer Inc.
- F. Hoffmann-La Roche AG
- Agilent Technologies
- Bio SB
- Cell Signaling Technology Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Immunohistochemistry Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Reagents
§ Histological Stains
§ Blocking Sera and Reagents
§ Chromogenic Substrates
§ Fixation Reagents
§ Stabilizers
§ Organic Solvents
§ Proteolytic Enzymes
§ Diluents
o Kits
o Antibodies
§ Primary Antibodies
§ Secondary Antibodies
o Equipment
§ Slide Staining Systems
§ Tissue Microarrays
§ Tissue Processing Systems
§ Slide Scanners
§ Others
o Immunohistochemistry Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Drug Testing
o Diagnostics
§ Cancer
§ Cardiovascular Diseases
§ Nephrological Diseases
§ Autoimmune Diseases
§ Infectious Diseases
§ Diabetes Mellitus
o Immunohistochemistry Market, By End-Use, Estimates and Forecast, 2017-2027 ($Million)
o Research Institutes
o Hospitals and Diagnostic Laboratories
o Others
Immunohistochemistry Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Immunohistochemistry Market, By Country
o U.S. Immunohistochemistry Market
o Canada Immunohistochemistry Market
o Mexico Immunohistochemistry Market
o Europe
§ Europe Immunohistochemistry Market, By Country
o Germany Immunohistochemistry Market
o UK Immunohistochemistry Market
o France Immunohistochemistry Market
o Russia Immunohistochemistry Market
o Italy Immunohistochemistry Market
o Rest of Europe Immunohistochemistry Market
o Asia-Pacific
§ Asia-Pacific Immunohistochemistry Market, By Country
o China Immunohistochemistry Market
o Japan Immunohistochemistry Market
o South Korea Immunohistochemistry Market
o India Immunohistochemistry Market
o Southeast Asia Immunohistochemistry Market
o Rest of Asia-Pacific Immunohistochemistry Market
o South America
§ South America Immunohistochemistry Market, By Country
o Brazil Immunohistochemistry Market
o Argentina Immunohistochemistry Market
o Columbia Immunohistochemistry Market
o Rest of South America Immunohistochemistry Market
o Middle East and Africa
§ Middle East and Africa Immunohistochemistry Market, By Country
o Saudi Arabia Immunohistochemistry Market
o UAE Immunohistochemistry Market
o Egypt Immunohistochemistry Market
o Nigeria Immunohistochemistry Market
o South Africa Immunohistochemistry Market
o Rest of MEA Immunohistochemistry Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Immunohistochemistry Market, By Product
5.1. Introduction
5.2. Global Immunohistochemistry Revenue and Market Share by Product (2017-2027)
5.2.1. Global Immunohistochemistry Revenue and Revenue Share by Product (2017-2027)
5.3. Reagents
5.3.1. Global Reagents Revenue and Growth Rate (2017-2027)
5.4. Kits
5.4.1. Global Kits Revenue and Growth Rate (2017-2027)
5.5. Antibodies
5.5.1. Global Antibodies Revenue and Growth Rate (2017-2027)
5.6. Equipment
5.6.1. Global Equipment Revenue and Growth Rate (2017-2027)
6. Immunohistochemistry Market, By Application
6.1. Introduction
6.2. Global Immunohistochemistry Revenue and Market Share by Application (2017-2027)
6.2.1. Global Immunohistochemistry Revenue and Revenue Share by Application (2017-2027)
6.3. Drug Testing
6.3.1. Global Drug Testing Revenue and Growth Rate (2017-2027)
6.4. Diagnostics
6.4.1. Global Diagnostics Revenue and Growth Rate (2017-2027)
7. Immunohistochemistry Market, By End-Use
7.1. Introduction
7.2. Global Immunohistochemistry Revenue and Market Share by End-Use (2017-2027)
7.2.1. Global Immunohistochemistry Revenue and Revenue Share by End-Use (2017-2027)
7.3. Research Institutes
7.3.1. Global Research Institutes Revenue and Growth Rate (2017-2027)
7.4. Hospitals and Diagnostic Laboratories
7.4.1. Global Hospitals and Diagnostic Laboratories Revenue and Growth Rate (2017-2027)
7.5. Others
7.5.1. Global Others Revenue and Growth Rate (2017-2027)
8. Immunohistochemistry Market, By Region
8.1. Introduction
8.2. Global Immunohistochemistry Revenue and Market Share by Regions
8.2.1. Global Immunohistochemistry Revenue by Regions (2017-2027)
8.3. North America Immunohistochemistry by Countries
8.3.1. North America Immunohistochemistry Revenue and Growth Rate (2017-2027)
8.3.2. North America Immunohistochemistry Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Immunohistochemistry by Countries
8.4.1. Europe Immunohistochemistry Revenue and Growth Rate (2017-2027)
8.4.2. Europe Immunohistochemistry Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Immunohistochemistry by Countries
8.5.1. Asia-Pacific Immunohistochemistry Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Immunohistochemistry Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Immunohistochemistry by Countries
8.6.1. South America Immunohistochemistry Revenue and Growth Rate (2017-2027)
8.6.2. South America Immunohistochemistry Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Immunohistochemistry by Countries
8.7.1. Middle East and Africa Immunohistochemistry Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Immunohistochemistry Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Thermo Fisher Scientific Inc.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Danaher Corporation
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. Abcam plc.
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Merck KGaA
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Bio-Rad Laboratories Inc.
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. PerkinElmer Inc.
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. F. Hoffmann-La Roche AG
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. Agilent Technologies
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. Bio SB
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
9.10. Cell Signaling Technology Inc.
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Revenue and Market Share
10. Global Immunohistochemistry Market Competition, by Manufacturer
10.1. Global Immunohistochemistry Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Immunohistochemistry Price By Region (2017-2017)
10.3. Top 5 Immunohistochemistry Manufacturer Market Share
10.4. Market Competition Trend
11. Immunohistochemistry Market Forecast (2017-2027)
11.1. Global Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Immunohistochemistry Market Forecast by Regions (2017-2027)
11.2.1. North America Immunohistochemistry Market Forecast (2017-2027)
11.2.1.1. United States Immunohistochemistry Market Forecast (2017-2027)
11.2.1.2. Canada Immunohistochemistry Market Forecast (2017-2027)
11.2.1.3. Mexico Immunohistochemistry Market Forecast (2017-2027)
11.2.2. Europe Immunohistochemistry Market Forecast (2017-2027)
11.2.2.1. Germany Immunohistochemistry Market Forecast (2017-2027)
11.2.2.2. France Immunohistochemistry Market Forecast (2017-2027)
11.2.2.3. UK Immunohistochemistry Market Forecast (2017-2027)
11.2.2.4. Russia Immunohistochemistry Market Forecast (2017-2027)
11.2.2.5. Italy Immunohistochemistry Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Immunohistochemistry Market Forecast (2017-2027)
11.2.3. Asia-Pacific Immunohistochemistry Market Forecast (2017-2027)
11.2.3.1. China Immunohistochemistry Market Forecast (2017-2027)
11.2.3.2. Japan Immunohistochemistry Market Forecast (2017-2027)
11.2.3.3. Korea Immunohistochemistry Market Forecast (2017-2027)
11.2.3.4. India Immunohistochemistry Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Immunohistochemistry Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Immunohistochemistry Market Forecast (2017-2027)
11.2.4. South America Immunohistochemistry Market Forecast (2017-2027)
11.2.4.1. Brazil Immunohistochemistry Market Forecast (2017-2027)
11.2.4.2. Argentina Immunohistochemistry Market Forecast (2017-2027)
11.2.4.3. Columbia Immunohistochemistry Market Forecast (2017-2027)
11.2.4.4. Rest of South America Immunohistochemistry Market Forecast (2017-2027)
11.2.5. Middle East and Africa Immunohistochemistry Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Immunohistochemistry Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Immunohistochemistry Market Forecast (2017-2027)
11.2.5.3. Egypt Immunohistochemistry Market Forecast (2017-2027)
11.2.5.4. Nigeria Immunohistochemistry Market Forecast (2017-2027)
11.2.5.5. South Africa Immunohistochemistry Market Forecast (2017-2027)
11.2.5.6. Turkey Immunohistochemistry Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Immunohistochemistry Market Forecast (2017-2027)
11.3. Immunohistochemistry Market Forecast by Product (2017-2027)
11.3.1. Immunohistochemistry Forecast by Product (2017-2027)
11.3.2. Immunohistochemistry Market Share Forecast by Product (2017-2027)
11.4. Immunohistochemistry Market Forecast by Application (2017-2027)
11.4.1. Immunohistochemistry Forecast by Application (2017-2027)
11.4.2. Immunohistochemistry Market Share Forecast by Application (2017-2027)
11.5. Immunohistochemistry Market Forecast by End-Use (2017-2027)
11.5.1. Immunohistochemistry Forecast by End-Use (2017-2027)
11.5.2. Immunohistochemistry Market Share Forecast by End-Use (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Immunohistochemistry Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Immunohistochemistry Revenue and Revenue Share by Product (2017-2018)
Figure Global Reagents Revenue and Growth Rate (2017-2018)
Figure Global Kits Revenue and Growth Rate (2017-2018)
Figure Global Antibodies Revenue and Growth Rate (2017-2018)
Figure Global Equipment Revenue and Growth Rate (2017-2018)
Table Global Immunohistochemistry Revenue and Revenue Share by Application (2017-2018)
Figure Global Drug Testing Revenue and Growth Rate (2017-2018)
Figure Global Diagnostics Revenue and Growth Rate (2017-2018)
Table Global Immunohistochemistry Revenue and Revenue Share by End-Use (2017-2018)
Figure Global Research Institutes Revenue and Growth Rate (2017-2018)
Figure Global Hospitals and Diagnostic Laboratories Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Immunohistochemistry Revenue by Regions (2017-2018)
Figure North America Immunohistochemistry Growth Rate (2017-2018)
Figure North America Immunohistochemistry Revenue and Growth Rate (2017-2018)
Figure North America Immunohistochemistry by Countries (2017-2018)
Figure North America Immunohistochemistry Revenue (Million USD) by Countries (2017-2018)
Figure United States Immunohistochemistry Growth Rate (2017-2018)
Figure United States Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Immunohistochemistry Growth Rate (2017-2018)
Figure Canada Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Immunohistochemistry Growth Rate (2017-2018)
Figure Mexico Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Immunohistochemistry Growth Rate (2017-2018)
Figure Europe Immunohistochemistry Revenue and Growth Rate (2017-2018)
Figure Europe Immunohistochemistry by Countries (2017-2018)
Figure Europe Immunohistochemistry Revenue (Million USD) by Countries (2017-2018)
Figure Germany Immunohistochemistry Growth Rate (2017-2018)
Figure Germany Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Immunohistochemistry Growth Rate (2017-2018)
Figure France Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Immunohistochemistry Growth Rate (2017-2018)
Figure UK Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Immunohistochemistry Growth Rate (2017-2018)
Figure Russia Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Immunohistochemistry Growth Rate (2017-2018)
Figure Italy Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Immunohistochemistry Growth Rate (2017-2018)
Figure Rest of Europe Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Immunohistochemistry Growth Rate (2017-2018)
Figure Asia-Pacific Immunohistochemistry Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Immunohistochemistry by Countries (2017-2018)
Figure Asia-Pacific Immunohistochemistry Revenue (Million USD) by Countries (2017-2018)
Figure China Immunohistochemistry Growth Rate (2017-2018)
Figure China Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Immunohistochemistry Growth Rate (2017-2018)
Figure Japan Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Immunohistochemistry Growth Rate (2017-2018)
Figure Korea Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Immunohistochemistry Growth Rate (2017-2018)
Figure India Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Immunohistochemistry Growth Rate (2017-2018)
Figure Southeast Asia Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Immunohistochemistry Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Immunohistochemistry Growth Rate (2017-2018)
Figure South America Immunohistochemistry Revenue and Growth Rate (2017-2018)
Figure South America Immunohistochemistry by Countries (2017-2018)
Figure South America Immunohistochemistry Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Immunohistochemistry Growth Rate (2017-2018)
Figure Brazil Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Immunohistochemistry Growth Rate (2017-2018)
Figure Argentina Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Immunohistochemistry Growth Rate (2017-2018)
Figure Columbia Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Immunohistochemistry Growth Rate (2017-2018)
Figure Rest of South America Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Immunohistochemistry Growth Rate (2017-2018)
Figure Middle East and Africa Immunohistochemistry Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Immunohistochemistry by Countries (2017-2018)
Figure Middle East and Africa Immunohistochemistry Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Immunohistochemistry Growth Rate (2017-2018)
Figure Saudi Arabia Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Immunohistochemistry Growth Rate (2017-2018)
Figure United Arab Emirates Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Immunohistochemistry Growth Rate (2017-2018)
Figure Egypt Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Immunohistochemistry Growth Rate (2017-2018)
Figure Nigeria Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Immunohistochemistry Growth Rate (2017-2018)
Figure South Africa Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Immunohistochemistry Growth Rate (2017-2018)
Figure Turkey Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Immunohistochemistry Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Immunohistochemistry Revenue (Millions USD) and Growth Rate (2017-2018)
Table Thermo Fisher Scientific Inc. Immunohistochemistry Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Danaher Corporation Immunohistochemistry Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abcam plc. Immunohistochemistry Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck KGaA Immunohistochemistry Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bio-Rad Laboratories Inc. Immunohistochemistry Price, Revenue, Gross Margin and Market Share (2017-2017)
Table PerkinElmer Inc. Immunohistochemistry Price, Revenue, Gross Margin and Market Share (2017-2017)
Table F. Hoffmann-La Roche AG Immunohistochemistry Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Agilent Technologies Immunohistochemistry Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bio SB Immunohistochemistry Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Cell Signaling Technology Inc. Immunohistochemistry Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Immunohistochemistry Market Share by Manufacturer
Figure Global Immunohistochemistry Revenue and Market Share by Manufacturer
Table Global Immunohistochemistry Price by Region (2017-2017)
Figure Top 5 Immunohistochemistry Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Immunohistochemistry Revenue (Millions USD) and Growth Rate (2018-2025)
Table Immunohistochemistry Market Forecast by Regions (2018-2025)
Figure North America Immunohistochemistry Market Forecast (2018-2025)
Figure United States Immunohistochemistry Market Forecast (2018-2025)
Figure Canada Immunohistochemistry Market Forecast (2018-2025)
Figure Mexico Immunohistochemistry Market Forecast (2018-2025)
Figure Europe Immunohistochemistry Market Forecast (2018-2025)
Figure Germany Immunohistochemistry Market Forecast (2018-2025)
Figure France Immunohistochemistry Market Forecast (2018-2025)
Figure UK Immunohistochemistry Market Forecast (2018-2025)
Figure Russia Immunohistochemistry Market Forecast (2018-2025)
Figure Italy Immunohistochemistry Market Forecast (2018-2025)
Figure Rest of Europe Immunohistochemistry Market Forecast (2018-2025)
Figure Asia-Pacific Immunohistochemistry Market Forecast (2018-2025)
Figure China Immunohistochemistry Market Forecast (2018-2025)
Figure Japan Immunohistochemistry Market Forecast (2018-2025)
Figure Korea Immunohistochemistry Market Forecast (2018-2025)
Figure India Immunohistochemistry Market Forecast (2018-2025)
Figure Southeast Asia Immunohistochemistry Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Immunohistochemistry Market Forecast (2018-2025)
Figure South America Immunohistochemistry Market Forecast (2018-2025)
Figure Brazil Immunohistochemistry Market Forecast (2018-2025)
Figure Argentina Immunohistochemistry Market Forecast (2018-2025)
Figure Columbia Immunohistochemistry Market Forecast (2018-2025)
Figure Rest of South America Immunohistochemistry Market Forecast (2018-2025)
Figure Middle East and Africa Immunohistochemistry Market Forecast (2018-2025)
Figure Saudi Arabia Immunohistochemistry Market Forecast (2018-2025)
Figure United Arab Emirates Immunohistochemistry Market Forecast (2018-2025)
Figure Egypt Immunohistochemistry Market Forecast (2018-2025)
Figure Nigeria Immunohistochemistry Market Forecast (2018-2025)
Figure South Africa Immunohistochemistry Market Forecast (2018-2025)
Figure Turkey Immunohistochemistry Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Immunohistochemistry Market Forecast (2018-2025)
Figure Global Immunohistochemistry Forecast by Product (2018-2025)
Figure Global Immunohistochemistry Market Share Forecast by Product (2018-2025)
Figure Global Immunohistochemistry Forecast by Product (2018-2025)
Figure Global Immunohistochemistry Forecast by Application (2018-2025)
Figure Global Immunohistochemistry Market Share Forecast by Application (2018-2025)
Figure Global Immunohistochemistry Forecast by Application (2018-2025)
Figure Global Immunohistochemistry Forecast by End-Use (2018-2025)
Figure Global Immunohistochemistry Market Share Forecast by End-Use (2018-2025)
Figure Global Immunohistochemistry Forecast by End-Use (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|